| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,041,100 | 793,600 | 922,200 | 1,458,700 | | Cost of Revenue | 929,200 | 766,600 | 923,000 | 1,344,700 | | | Gross Profit | 111,900 | 27,000 | (800) | 114,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,600 | 47,900 | 47,800 | 55,500 | | Non Recurring |
-
|
-
|
-
| 699,500 | | Others | 51,000 | 51,600 | 51,300 | 48,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,300 | (72,500) | (99,900) | (689,200) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,900 | 3,400 | 2,300 | 1,900 | | Earnings Before Interest And Taxes | 18,200 | (69,100) | (97,600) | (687,300) | | Interest Expense | 9,000 | 9,200 | 10,200 | 11,600 | | Income Before Tax | 9,200 | (78,300) | (107,800) | (698,900) | | Income Tax Expense | 3,500 | (30,300) | (34,200) | (268,300) | | Minority Interest | 1,500 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,200 | (48,000) | (73,600) | (430,600) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,200 | (48,000) | (73,600) | (430,600) | | Preferred Stock And Other Adjustments | (1,000) | 800 | 200 |
-
| | | Net Income Applicable To Common Shares | $6,200 | ($47,200) | ($73,400) | ($430,600) |
|
0.51% Nasdaq 
Income Statement
